首页> 外文期刊>Development >Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice.
【24h】

Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice.

机译:胰岛素样生长因子结合蛋白5(IGFBP-5)在转基因小鼠的乳腺中诱导细胞过早死亡。

获取原文
获取原文并翻译 | 示例
       

摘要

We have previously demonstrated that IGFBP-5 production by mammary epithelial cells increases dramatically during involution of the mammary gland. To demonstrate a causal relationship between IGFBP-5 and cell death we created transgenic mice expressing IGFBP-5 in the mammary gland using a mammary-specific promoter, beta-lactoglobulin. DNA content in the mammary glands of transgenic mice was decreased as early as day 10 of pregnancy. Histological analysis indicated reduced numbers of alveolar end buds, with decreased ductal branching. Transgenic dams produced IGFBP-5 in their milk at concentrations similar to those achieved at the end of normal lactation. Mammary cell number and milk synthesis were both decreased by approximately 50% during the first 10 days of lactation. BrdU labelling was decreased, whereas DNA ladders were increased in transgenic animals on day 1 of lactation. On day 2 postpartum, the epithelial invasion of the mammary fat pad was clearly impaired in transgenic animals. The concentrations of the pro-apoptotic molecule caspase-3 and of plasmin were both increased in transgenic animals whilst the concentrations of 2 prosurvival molecules Bcl-2 and Bcl-x(L)were both decreased. In order to examine whether IGFBP-5 acts by inhibiting the survival effect of IGF-I we examined IGF receptor phosphorylation and Akt phosphorylation and showed that both were inhibited. We attempted to "rescue" the transgenic phenotype by using growth hormone to increase endogenous IGF-I concentrations or by implanting minipumps delivering an IGF-1 analogue, R(3)-IGF-1, which binds weakly to IGFBP-5. Growth hormone treatment failed to affect mammary development suggesting that increased concentrations of endogenous IGF-1 are insufficient to overcome the high concentrations of IGFBP-5 produced by these transgenic animals. In contrast mammary development (gland weight and DNA content) was normalised by R3-IGF-I although milk production was only partially restored. This is the first demonstration that over-expression of IGFBP-5 can lead to; impaired mammary development, increased expression of the pro-apoptotic molecule caspase-3, increased plasmin generation and decreased expression of pro-survival molecules of the Bcl-2 family. It clearly demonstrates that IGF-I is an important developmental/survival factor for the mammary gland and, furthermore, this cell death programme may be utilised in a wide variety of tissues.
机译:先前我们已经证明,在乳腺退化期间,乳腺上皮细胞产生的IGFBP-5数量急剧增加。为了证明IGFBP-5与细胞死亡之间的因果关系,我们使用乳腺特异性启动子β-乳球蛋白创建了在乳腺中表达IGFBP-5的转基因小鼠。早在怀孕的第10天,转基因小鼠的乳腺中的DNA含量就降低了。组织学分析表明,肺泡末端芽的数量减少,导管分支减少。转基因母乳在牛奶中产生的IGFBP-5浓度与正常泌乳结束时达到的浓度相似。在哺乳的前10天中,乳腺细胞数量和牛奶合成量均下降了约50%。在哺乳第1天,转基因动物的BrdU标记减少,而DNA阶梯增加。产后第二天,转基因动物的乳腺脂肪垫上皮浸润明显受损。转基因动物中促凋亡分子胱天蛋白酶3和纤溶酶的浓度均升高,而2种存活分子Bcl-2和Bcl-x(L)的浓度均降低。为了检查IGFBP-5是否通过抑制IGF-1的存活作用而起作用,我们检查了IGF受体的磷酸化和Akt的磷酸化,并表明两者均被抑制。我们试图通过使用生长激素增加内源性IGF-1的浓度或通过植入传递IGF-1类似物R(3)-IGF-1的微型泵来“拯救”转基因表型,该IGF-1类似物与IGFBP-5的结合较弱。生长激素治疗未能影响乳腺发育,表明内源性IGF-1浓度的增加不足以克服这些转基因动物产生的IGFBP-5的高浓度。相比之下,尽管乳汁生产仅部分恢复,但乳腺发育(腺重和DNA含量)通过R3-IGF-1进行了标准化。这是IGFBP-5过度表达可能导致的第一个证明。乳腺发育受损,促凋亡分子caspase-3表达增加,纤溶酶生成增加以及Bcl-2家族促生存分子表达降低。它清楚地表明,IGF-I是乳腺的重要发育/存活因子,此外,该细胞死亡程序可用于多种组织。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号